Exenatide once weekly suspension: Phase I/II started

Amylin began a double-blind, placebo-controlled, U.S. Phase I/II trial of a premixed suspension formulation of exenatide once weekly in 65 patients and healthy volunteers. Healthy volunteers will rece...